(Q35172136)

6 August 2017

1 reference

title

Autologous hematopoietic stem cell transplantation for Crohn's disease (English)

1 reference

6 August 2017

0 references

Robert M Craig

1

1 reference

6 August 2017

publication date

1 August 2002

1 reference

6 August 2017

1 reference

6 August 2017

volume

1

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

244-249

1 reference

Immunologic mechanisms in intestinal diseases

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Escherichia coli antibodies in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Are the focal microscopic jejunal lesions in Crohn's disease produced by a T-cell-mediated immune response?

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Controlled trial of azathioprine in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Course of Crohn's disease after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Case of Crohn's disease in bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Autologous bone marrow transplantation for non-Hodgkin's lymphoma resulting in long-term remission of coincidental Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Stem cell transplantation for inflammatory bowel disease: practical and ethical issues

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

Allogeneic bone marrow transplantation in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900058-7

7 January 2021

10.1016/S1568-9972(02)00058-7

Identifiers

DOI

1 reference

6 August 2017

1 reference